Global Frontier Investments LLC Atai Life Sciences N.V. Transaction History

Global Frontier Investments LLC

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.27 - $2.6 $0 - $0	0 New	0 $0
Q1 2024 May 15, 2024	BUY	$1.5 - $2.19 $0 - $0	0 New	0 $0
Q4 2023 Mar 13, 2024	BUY	$1.04 - $1.55 $0 - $0	0 New	0 $0
Q3 2023 Dec 06, 2023	BUY	$1.27 - $2.28 $0 - $0	0 New	0 $0
Q2 2023 Aug 16, 2023	BUY	$1.44 - $2.19 $0 - $0	0 New	0 $0
Q1 2023 May 12, 2023	BUY	$1.17 - $2.7 $0 - $0	0 New	0 $0
Q4 2022 Feb 08, 2023	BUY	$2.38 - $3.55 $0 - $0	0 New	0 $0
Q3 2022 Nov 14, 2022	SELL	$3.14 - $4.87 $210,380 - $326,290	-67,000 Closed	0 $0
Q2 2022 Aug 09, 2022	SELL	$3.03 - $5.32 $227,249 - $399,000	-75,000 Reduced 52.82%	67,000 $244,000
Q1 2022 May 10, 2022	SELL	$4.66 - $7.66 $233,000 - $383,000	-50,000 Reduced 26.04%	142,000 $723,000
Q3 2021 Nov 15, 2021	BUY	$13.62 - $19.48 $2.62 Million - $3.74 Million	192,000 New	192,000 $2.84 Million

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $204M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Global Frontier Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Global Frontier Investments LLC with notifications on news.